The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients

The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients

Background Solid organ transplantation is associated with increased risk of non-melanoma skin cancer. Studies with short follow up times have suggested a reduced occurrence of these cancers in recipients treated with mammalian target of rapamycin inhibitors as maintenance immunosuppression. We aimed...

Full description

Bibliographic Details
Main Authors: Susan L. Murray, Fergus E. Daly, Patrick O’Kelly, Eamonn O’Leary, Sandra Deady, James P. O’Neill, Alexander Dudley, Nicholas R. Rutledge, Aiden McCormick, Diarmuid D. Houlihan, Yvonne Williams, Patrick G. Morris, Siona Ni Raghallaigh, Fergal J. Moloney, Donal J. Sexton, Peter J. Conlon
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Renal Failure
Subjects:
immunosuppression
cancer
skin cancer
mtor inhibitor
renal transplant
liver transplant
Online Access:http://dx.doi.org/10.1080/0886022X.2020.1785499

Internet

http://dx.doi.org/10.1080/0886022X.2020.1785499

Similar Items